Evidence map›Paper›PMID 24310428›Full record

ArticlePharmaceutics2011

Cell migration and invasion assays as tools for drug discovery.

Keren I Hulkower, Renee L Herber

Abstract read
In one paragraph

Article in Pharmaceutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Wound Healing Assay.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Modelling metastasis in a dish:Pathology oncology research : POR · 2025
    Review
  20. Review

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Keren I HulkowerPlatypus Technologies, LLC, 5520 Nobel Drive, Suite 100, Madison, WI 53711, USA. khulkower@platypustech.com.
Renee L Herber

Funding

High throughput cell migration assay amenable to high content imagingR44GM090386 · NIGMS · PLATYPUS TECHNOLOGIES, LLC · PI BURLAND, TIMOTHY GEORGE · 2011 to 2012
$789k
Transformative HTS cell migration assay for rapid screening of cancer therapeuticR21CA147985 · NCI · PLATYPUS TECHNOLOGIES, LLC · PI ACHARYA, BHARAT R, VOGT, ANDREAS · 2010 to 2011
$336k
NCI NIH HHS R21 CA147985NIGMS NIH HHS R44 GM090386
6 · The paper itself

Abstract

Cell migration and invasion are processes that offer rich targets for intervention in key physiologic and pathologic phenomena such as wound healing and cancer metastasis. With the advent of high-throughput and high content imaging systems, there has been a movement towards the use of physiologically relevant cell-based assays earlier in the testing paradigm. This allows more effective identification of lead compounds and recognition of undesirable effects sooner in the drug discovery screening process. This article will review the effective use of several principle formats for studying cell motility: scratch assays, transmembrane assays, microfluidic devices and cell exclusion zone assays.

Identifiers

PMID24310428
PMCPMC3857040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.